Stocks Touched New Highs: Johnson & Johnson (NYSE:JNJ), Aetna Inc (NYSE:AET), BioDelivery Sciences International (NASDAQ:BDSI), CIGNA Corporation (NYSE:CI), Humana (NYSE:HUM)

The IDIX acquisition deal tantalized ACHN investors largely because all and sundry are aware of the contention that MRK had to face during its acquisition process, with a major research based pharma company, AbbVie Inc (NYSE:ABBV) and another prime name in the healthcare industry – Johnson & Johnson (NYSE:JNJ). Johnson & Johnson (NYSE:JNJ) stock performance was -0.75% in last session and finished the day at … Continue reading Stocks Touched New Highs: Johnson & Johnson (NYSE:JNJ), Aetna Inc (NYSE:AET), BioDelivery Sciences International (NASDAQ:BDSI), CIGNA Corporation (NYSE:CI), Humana (NYSE:HUM)

Kevin Long06/12

Hot Watch List: The Procter & Gamble Company (NYSE:PG), AVX Corporation (NYSE:AVX), Google Inc (NASDAQ:GOOGL), Johnson & Johnson (NYSE:JNJ), Wal-Mart Stores (NYSE:WMT)

The Procter & Gamble Company (NYSE:PG), and brewers AB InBev and Greene King have all launched new products and variants recently, and although their strategies differ, each has similar goals: to achieve greater penetration among current customers or appeal to new ones. The Procter & Gamble Company (NYSE:PG) stock performance was -0.09% in last session and finished the day at $79.86. Traded volume was 5.43million … Continue reading Hot Watch List: The Procter & Gamble Company (NYSE:PG), AVX Corporation (NYSE:AVX), Google Inc (NASDAQ:GOOGL), Johnson & Johnson (NYSE:JNJ), Wal-Mart Stores (NYSE:WMT)

Richard Atkins06/05

FB Nasdaq FB Facebook

Healthcare Active Stocks: Johnson & Johnson (NYSE:JNJ), Endo International (NASDAQ:ENDP), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)

Johnson & Johnson (NYSE: JNJ) has inked a global licensing deal with the privately held Aduro BioTech for developing new therapies to treat prostate cancer. According to the oncology deal, the private company granted Janssen Biotech, a division of Johnson & Johnson, the exclusive license to certain candidates specifically engineered for the treatment of prostate cancer on the basis of Aduro’s proprietary live-attenuated double-deleted (LADD) … Continue reading Healthcare Active Stocks: Johnson & Johnson (NYSE:JNJ), Endo International (NASDAQ:ENDP), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)

John Bellich06/02